North American cost analysis of brand name versus generic drugs for the treatment of glaucoma
Monali S Malvankar-Mehta,1,2 Lucy Feng,3 Cindy ML Hutnik1,4 1Department of Ophthalmology, Schulich School of Medicine and Dentistry, The University of Western Ontario, London, Ontario N6A 4V2, Canada; 2Department of Epidemiology and Biostatistics, Schulich School of Medicine and Dentistry, The Unive...
Saved in:
Main Authors: | Malvankar-Mehta MS (Author), Feng L (Author), Hutnik CML (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2019-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The concept of: Generic drugs and patented drugs Vs brand name drugs and non-proprietary (generic) name drugs.
by: Karan eThakkar, et al.
Published: (2013) -
The value of corneoscleral rim cultures in keratoplasty: a systematic review and cost-effectiveness analysis
by: Kiatos E, et al.
Published: (2017) -
Generic versus brand-name over-the-counter analgesics: knowledge and attitudes among Swedish pharmacy customers
by: Helle Håkonsen, et al.
Published: (2020) -
Clinical equivalence of generic and brand-name drugs used in cardiology: what do we know?
by: Marina V. Leonova
Published: (2021) -
Comparison of Pharmaceutical Characteristics between Brand-Name Meropenem and Its Generics
by: Ping Yang, et al.
Published: (2021)